OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
Catherine Leroy, Sacha Spelier, Nadège Charlène Essonghé, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 970-985
Open Access | Times Cited: 13
Catherine Leroy, Sacha Spelier, Nadège Charlène Essonghé, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 970-985
Open Access | Times Cited: 13
Showing 13 citing articles:
Readthrough compounds for nonsense mutations: bridging the translational gap
Sacha Spelier, Eveline P.M. van Doorn, Cornelis K. van der Ent, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 297-314
Open Access | Times Cited: 33
Sacha Spelier, Eveline P.M. van Doorn, Cornelis K. van der Ent, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 297-314
Open Access | Times Cited: 33
Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms
Luyang Cao, Yong Wu, Yanchun Gong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116120-116120
Closed Access | Times Cited: 6
Luyang Cao, Yong Wu, Yanchun Gong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116120-116120
Closed Access | Times Cited: 6
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons
Nesrine Benslimane, Camille Loret, Pauline Chazelas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 314-314
Open Access | Times Cited: 5
Nesrine Benslimane, Camille Loret, Pauline Chazelas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 314-314
Open Access | Times Cited: 5
Molecular mechanisms of eukaryotic translation fidelity and their associations with diseases
Dejiu Zhang, Lei Zhu, Fei Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124680-124680
Closed Access | Times Cited: 13
Dejiu Zhang, Lei Zhu, Fei Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124680-124680
Closed Access | Times Cited: 13
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
Shan Li, Juan Li, Wenjing Shi, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 988-988
Open Access | Times Cited: 13
Shan Li, Juan Li, Wenjing Shi, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 988-988
Open Access | Times Cited: 13
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches
Pedro Morais, R. Zhang, Yi‐Tao Yu
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 3
Pedro Morais, R. Zhang, Yi‐Tao Yu
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 3
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9609-9609
Open Access | Times Cited: 8
Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9609-9609
Open Access | Times Cited: 8
Development of precision therapies for rare inborn errors of metabolism: Functional investigations in cell culture models
Miroslava Didiášová, Antje Banning, Ritva Tikkanen
Journal of Inherited Metabolic Disease (2023) Vol. 47, Iss. 3, pp. 509-516
Open Access | Times Cited: 4
Miroslava Didiášová, Antje Banning, Ritva Tikkanen
Journal of Inherited Metabolic Disease (2023) Vol. 47, Iss. 3, pp. 509-516
Open Access | Times Cited: 4
An HERV-W ENV transcription in atypical memory B cells linked to COVID-19 evolution and risk for long COVID can express the encoded protein from a ribosome readthrough of mRNA from chromosome X.
Joanna Brunel, Julien Paganini, Mélissa Galloux, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Joanna Brunel, Julien Paganini, Mélissa Galloux, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency
Alice M. Todaro, Claudia Maria Radu, Maria Ciccone, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 2, pp. 410-422
Closed Access | Times Cited: 2
Alice M. Todaro, Claudia Maria Radu, Maria Ciccone, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 2, pp. 410-422
Closed Access | Times Cited: 2
HERV-W ENV transcription in B cells predicting symptomatic COVID-19 and risk for long COVID can express a full-length protein despite stop codon in mRNA from chromosome X via a ribosome readthrough.
Joanna Brunel, Julien Paganini, Mélissa Galloux, et al.
Microbes and Infection (2024), pp. 105431-105431
Closed Access
Joanna Brunel, Julien Paganini, Mélissa Galloux, et al.
Microbes and Infection (2024), pp. 105431-105431
Closed Access
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR function
M. Michicich, Zachary Traylor, C. P. McCoy, et al.
Journal of Cystic Fibrosis (2024)
Open Access
M. Michicich, Zachary Traylor, C. P. McCoy, et al.
Journal of Cystic Fibrosis (2024)
Open Access
The power of 2,6-diaminopurine in correcting UGA nonsense codons in CFTR mRNA
Luı́sa Romão
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 921-922
Open Access
Luı́sa Romão
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 921-922
Open Access
